国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Aspergillus clavatus Nitrogen permease regulator 3 (npr3), partial CSB-YP373058AVC
CSB-EP373058AVC
CSB-BP373058AVC
CSB-MP373058AVC
CSB-EP373058AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus U3 small nucleolar RNA-associated protein 25 (utp25), partial CSB-YP373059AVC
CSB-EP373059AVC
CSB-BP373059AVC
CSB-MP373059AVC
CSB-EP373059AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable cytosolic iron-sulfur protein assembly protein 1 (cia1) CSB-YP373060AVC
CSB-EP373060AVC
CSB-BP373060AVC
CSB-MP373060AVC
CSB-EP373060AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Fe-S cluster assembly protein dre2 (dre2) CSB-YP373061AVC
CSB-EP373061AVC
CSB-BP373061AVC
CSB-MP373061AVC
CSB-EP373061AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Histone H2A.Z-specific chaperone chz1 (chz1) CSB-YP373062AVC
CSB-EP373062AVC
CSB-BP373062AVC
CSB-MP373062AVC
CSB-EP373062AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus ATP-dependent rRNA helicase rrp3 (rrp3) CSB-YP373063AVC
CSB-EP373063AVC
CSB-BP373063AVC
CSB-MP373063AVC
CSB-EP373063AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable beta-glucosidase A (bglA), partial CSB-YP373064AVC
CSB-EP373064AVC
CSB-BP373064AVC
CSB-MP373064AVC
CSB-EP373064AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus tRNA (guanine-N (7)-)-methyltransferase subunit trm82 CSB-YP373065AVC
CSB-EP373065AVC
CSB-BP373065AVC
CSB-MP373065AVC
CSB-EP373065AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Small COPII coat GTPase sar1 (sar1) CSB-YP373066AVC
CSB-EP373066AVC
CSB-BP373066AVC
CSB-MP373066AVC
CSB-EP373066AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable xyloglucan-specific endo-beta-1,4-glucanase A (xgeA) CSB-YP373067AVC
CSB-EP373067AVC
CSB-BP373067AVC
CSB-MP373067AVC
CSB-EP373067AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Polyadenylate-binding protein, cytoplasmic and nuclear (pab1), partial CSB-YP373068AVC
CSB-EP373068AVC
CSB-BP373068AVC
CSB-MP373068AVC
CSB-EP373068AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable endonuclease lcl3 (lcl3), partial CSB-YP373069AVC1
CSB-EP373069AVC1
CSB-BP373069AVC1
CSB-MP373069AVC1
CSB-EP373069AVC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus ATP-dependent DNA helicase mph1 (mph1), partial CSB-YP373070AVC
CSB-EP373070AVC
CSB-BP373070AVC
CSB-MP373070AVC
CSB-EP373070AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Leukotriene A-4 hydrolase homolog (ACLA_079530), partial CSB-YP373071AVC
CSB-EP373071AVC
CSB-BP373071AVC
CSB-MP373071AVC
CSB-EP373071AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus ATP-dependent RNA helicase mrh4, mitochondrial (mrh4), partial CSB-YP373072AVC
CSB-EP373072AVC
CSB-BP373072AVC
CSB-MP373072AVC
CSB-EP373072AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable cutinase 1 (ACLA_081180) CSB-YP373073AVC
CSB-EP373073AVC
CSB-BP373073AVC
CSB-MP373073AVC
CSB-EP373073AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable HECT-type ubiquitin ligase-interacting protein creD (creD), partial CSB-YP373074AVC
CSB-EP373074AVC
CSB-BP373074AVC
CSB-MP373074AVC
CSB-EP373074AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable glucan 1,3-beta-glucosidase D (exgD), partial CSB-YP373075AVC
CSB-EP373075AVC
CSB-BP373075AVC
CSB-MP373075AVC
CSB-EP373075AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable feruloyl esterase B (faeB), partial CSB-YP373076AVC
CSB-EP373076AVC
CSB-BP373076AVC
CSB-MP373076AVC
CSB-EP373076AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus ATP-dependent RNA helicase mak5 (mak5), partial CSB-YP373077AVC
CSB-EP373077AVC
CSB-BP373077AVC
CSB-MP373077AVC
CSB-EP373077AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>